WO2005113812A8 - Collections of matched biological reagents and methods for identifying matched reagents - Google Patents

Collections of matched biological reagents and methods for identifying matched reagents

Info

Publication number
WO2005113812A8
WO2005113812A8 PCT/US2005/013914 US2005013914W WO2005113812A8 WO 2005113812 A8 WO2005113812 A8 WO 2005113812A8 US 2005013914 W US2005013914 W US 2005013914W WO 2005113812 A8 WO2005113812 A8 WO 2005113812A8
Authority
WO
WIPO (PCT)
Prior art keywords
reagents
matched
biological
methods
collections
Prior art date
Application number
PCT/US2005/013914
Other languages
French (fr)
Other versions
WO2005113812A2 (en
Inventor
John Carrino
Feng Liang
Siamek Baharloo
Barry I Schweitzer
Original Assignee
Invitrogen Corp
John Carrino
Feng Liang
Siamek Baharloo
Barry I Schweitzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/830,074 external-priority patent/US20050240352A1/en
Application filed by Invitrogen Corp, John Carrino, Feng Liang, Siamek Baharloo, Barry I Schweitzer filed Critical Invitrogen Corp
Priority to JP2007509690A priority Critical patent/JP2007535040A/en
Priority to EP05779954A priority patent/EP1743039A2/en
Publication of WO2005113812A2 publication Critical patent/WO2005113812A2/en
Publication of WO2005113812A8 publication Critical patent/WO2005113812A8/en
Priority to US11/371,354 priority patent/US20060275794A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/10—Ontologies; Annotations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioethics (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Provided herein are collections of matched biological reagents selected from a larger collection of biological reagents, wherein the collection of matched biological reagents relate to a biological element. Also provided are methods for selling an isolated biomolecule or biological research reagent in a collection of matched biological reagents, and methods for selecting an isolated biomolecule or biological research reagent from a collection of biological reagents.
PCT/US2005/013914 2004-04-23 2005-04-22 Collections of matched biological reagents and methods for identifying matched reagents WO2005113812A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2007509690A JP2007535040A (en) 2004-04-23 2005-04-22 Collection of compatible biological reagents and methods for identifying compatible reagents
EP05779954A EP1743039A2 (en) 2004-04-23 2005-04-22 Collections of matched biological reagents and methods for identifying matched reagents
US11/371,354 US20060275794A1 (en) 2005-03-07 2006-03-07 Collections of matched biological reagents and methods for identifying matched reagents

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US10/830,074 US20050240352A1 (en) 2004-04-23 2004-04-23 Online procurement of biologically related products/services using interactive context searching of biological information
US10/830,074 2004-04-23
US58794104P 2004-07-14 2004-07-14
US58815804P 2004-07-14 2004-07-14
US60/588,158 2004-07-14
US60/587,941 2004-07-14
US59154104P 2004-07-26 2004-07-26
US60/591,541 2004-07-26
US59223904P 2004-07-28 2004-07-28
US60/592,239 2004-07-28
US60829304P 2004-09-08 2004-09-08
US60/608,293 2004-09-08
US65139005P 2005-02-08 2005-02-08
US60/651,390 2005-02-08
US95358605P 2005-02-15 2005-02-15
US60/953,586 2005-02-15
US65949205P 2005-03-07 2005-03-07
US60/659,492 2005-03-07
US66520005P 2005-03-25 2005-03-25
US60/665,200 2005-03-25
US1005705A 2005-04-19 2005-04-19
US67304505P 2005-04-19 2005-04-19
US60/673,045 2005-04-19

Publications (2)

Publication Number Publication Date
WO2005113812A2 WO2005113812A2 (en) 2005-12-01
WO2005113812A8 true WO2005113812A8 (en) 2006-02-02

Family

ID=35428938

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/013914 WO2005113812A2 (en) 2004-04-23 2005-04-22 Collections of matched biological reagents and methods for identifying matched reagents

Country Status (1)

Country Link
WO (1) WO2005113812A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9422539B2 (en) 2010-07-12 2016-08-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1989328A4 (en) * 2006-02-23 2009-07-01 Univ Johns Hopkins Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
KR100954322B1 (en) * 2006-06-14 2010-04-21 주식회사 엘지생명과학 Gene familyLBFL313 associated with pancreatic cancer
JP5354634B2 (en) * 2007-01-25 2013-11-27 国立大学法人大阪大学 Human ABH8 protein, gene encoding it, and therapeutic or diagnostic uses thereof
DK2126064T3 (en) * 2007-03-27 2012-09-10 Intrexon Corp MEK ligands and polynucleotides for encoding MEK ligands
JP5680407B2 (en) * 2007-06-04 2015-03-04 センター フォー アディクション アンド メンタル ヘルス FHL1 mutations associated with a novel X-linked myopathy
WO2008151428A1 (en) * 2007-06-11 2008-12-18 University Of Western Ontario Novel compositions for modulating mrna translation
EP2217618A2 (en) * 2007-10-02 2010-08-18 Universität zu Köln Novel marker genes for regulatory t cells from human blood
EP2397157A4 (en) * 2009-02-11 2013-05-01 Univ Tokyo Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
WO2010107825A2 (en) 2009-03-16 2010-09-23 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
EP2501414B1 (en) * 2009-11-17 2018-01-10 The Trustees Of The University Of Pennsylvania Smndelta7 degron: novel compositions and methods of use
EP2563381B1 (en) * 2010-04-27 2017-08-09 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
JP5843170B2 (en) * 2010-09-30 2016-01-13 国立研究開発法人理化学研究所 Method for treating glioma, method for examining glioma, method for delivering desired substance to glioma, and drug used in these methods
CN114601937A (en) * 2012-07-19 2022-06-10 宾夕法尼亚州研究基金会 Regenerating functional neurons for treatment of disease and injury in the nervous system
WO2014139182A1 (en) 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US20160176943A1 (en) * 2013-07-05 2016-06-23 Inserm (Insititut National De La Sante Et De La Recherche Medicale) Novel alternative splice transcripts for mhc class i related chain alpha (mica) and uses thereof
GB201415273D0 (en) * 2014-08-28 2014-10-15 Thermo Fisher Scient Bremen Data processing device and method for the evaluation of mass spectrometry data
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10429342B2 (en) 2014-12-18 2019-10-01 Edico Genome Corporation Chemically-sensitive field effect transistor
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
WO2017201081A1 (en) 2016-05-16 2017-11-23 Agilome, Inc. Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids
WO2018151952A1 (en) * 2017-02-16 2018-08-23 Becton, Dickinson And Company Methods and systems for providing epitope tagged biomolecules
US11767520B2 (en) 2017-04-20 2023-09-26 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
EP3953373A4 (en) * 2019-02-11 2023-09-13 Hope Permanente, LLC Production and uses of artificial histone h1 for analyzing, diagnosing, treating, and/or preventing senescence
WO2023081455A2 (en) * 2021-11-08 2023-05-11 Memorial Sloan-Kettering Cancer Center Immune cells expressing glucose transporter 5 (gluts) and compositions and methods including the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9328340B2 (en) 2009-12-11 2016-05-03 Atyr Pharma, Inc. Amino acyl tRNA synthetases for modulating inflammation
US9540628B2 (en) 2009-12-11 2017-01-10 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9422539B2 (en) 2010-07-12 2016-08-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9273302B2 (en) 2012-02-16 2016-03-01 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates

Also Published As

Publication number Publication date
WO2005113812A2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
WO2005113812A8 (en) Collections of matched biological reagents and methods for identifying matched reagents
SG131130A1 (en) Biochip for sorting and lysing biological samples
WO2007065025A3 (en) Method of dna analysis using micro/nanochannel
WO2007086900A3 (en) Stilbazium research assays
EP2266996A3 (en) New labelling strategies for the sensitive detection of analytes
WO2006121997A3 (en) Self-contained biological analysis
WO2004051218A3 (en) Multiplex amplification of polynucleotides
HK1095381A1 (en) Sample collection cup with integrated sample analysis system
WO2008039996A3 (en) Multi-detector gas identification system
WO2008048970A3 (en) Synthetic antibodies
IL175629A0 (en) Sample collection cup with integrated activatable sample analysis system
AU2002311773A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
WO2004070020A3 (en) Glyphosate tolerant alfalfa events and methods for detection thereof
WO2007039290A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
WO2007035929A3 (en) Method for detecting and quantitating multiple subcellular components
WO2011046614A3 (en) Methods and systems for phylogenetic analysis
EP1668338A4 (en) Automated cytological sample classification
WO2007037910A3 (en) Specific removal of activated immune cells
WO2004066937A3 (en) Antibodies specific for plasmacytoid dendritic cells
WO2007094752A3 (en) Biobriefcase
MXPA01005698A (en) Assay for anti transglutaminase antibodies detection useful in celiac disease diagnosis.
WO2007033367A3 (en) Salivary protein and rna for breast cancer detection
WO2006060739A3 (en) Ubiquitin ligase assays and related reagents
WO2001069247A3 (en) Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 48/2005 UNDER (30) REPLACE "INV-1005-PV7" BY "60/673,045"

D17 Declaration under article 17(2)a
WWE Wipo information: entry into national phase

Ref document number: 2007509690

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005779954

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005779954

Country of ref document: EP